Heart disease remains the leading cause of premature death in the U.S., making comprehensive cardiac evaluation a critical part of preventive care. Many forms of coronary artery disease develop silently, often years before symptoms appear.

A Coronary Computed Tomography Angiography (CCTA) is a non-invasive heart imaging study that uses advanced CT technology and intravenous contrast to directly visualize the coronary arteries. Unlike traditional cardiac tests that estimate risk indirectly, a CCTA allows us to see plaque buildup, blockages, and narrowing of the arteries, often before symptoms arise.

AI-Powered Analysis

We partner with Cleerly, an AI-driven platform that precisely measures coronary plaque volume, composition, length, and location. This helps identify early-stage and non-calcified plaque that may not appear on calcium scoring but still carries meaningful risk.

We also incorporate HeartFlow analysis to assess how plaque affects blood flow to the heart muscle, helping determine whether a blockage is not only present, but also functionally significant.

Together, CCTA imaging, Cleerly plaque analysis, and HeartFlow provide a comprehensive and personalized picture of cardiovascular health, supporting earlier detection, targeted prevention, and more informed decision-making.